Insider Shareholders with Direct Ownership of Altimmune, Inc. (ALT)
This section provides a comprehensive overview of the insiders with direct ownership of Altimmune, Inc. (ALT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Altimmune, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Vipin K Garg
President and CEO |
128,076 | 159,822 | 292,028 $2.41 Million | 46 |
Feb 02, 2024
Reduced 2.79%
|
|
Matthew Scott Harris
Chief Medical Officer |
94,622 | 47,587 | 55,119 $454,731 | 24 |
Jul 31, 2024
Added 2.63%
|
|
Richard I Eisenstadt
Chief Financial Officer |
53,259 | 8,247 | 45,012 $371,349 | 11 |
Jan 31, 2024
Added 9.31%
|
|
M Scot Roberts
Chief Scientific Officer |
127,475 | 93,559 | 43,310 $357,307 | 28 |
Jul 31, 2024
Added 1.48%
|
|
Mitchel Sayare
Director |
25,275 | 0 | 26,363 $217,494 | 1 |
Sep 24, 2020
Added 48.95%
|
|
David Drutz
Director |
19,528 | 0 | 20,151 $166,245 | 8 |
Nov 18, 2022
Added 0.69%
|
|
William Michael Brown
Chief Financial Officer |
1,740 | 0 | 17,721 $146,198 | 2 |
Jul 31, 2021
Added 4.33%
|
|
Raymond M Jordt
Chief Business Officer |
17,154 | 2,503 | 14,660 $120,945 | 5 |
Jul 31, 2024
Added 5.89%
|
|
Andrew Shutterly
Acting Chief Financial Officer |
1,259 | 0 | 11,372 $93,819 | 1 |
Jul 31, 2024
Added 9.97%
|
|
Klaus Schafer
Director |
19,129 | 10,150 | 9,179 $75,726 | 4 |
Jun 20, 2022
Added 0.65%
|
|
Philip Hodges
Director |
16,850 | 8,500 | 8,731 $72,030 | 3 |
Mar 01, 2021
Reduced 40.73%
|
|
Wayne Pisano
Director |
36,850 | 30,352 | 8,498 $70,108 | 4 |
Dec 22, 2022
Reduced 70.18%
|
|
John Gill
Director |
16,850 | 11,139 | 2,771 $22,860 | 3 |
Aug 12, 2022
Reduced 49.48%
|
|
Diane Jorkasky
Director |
17,610 | 17,610 | 0 $0 | 2 |
Jun 27, 2022
Reduced 100.0%
|